Figure 1: Cytokine concentrations and macrophage percentages in peritoneal wash solutions. (a) Flow cytometric analysis of peritoneal macrophages in control participants and endometriosis patients; (b) percentages of CD86+ macrophages; (c) percentages of CD163+ macrophages; (d) ratio of CD163+/CD86+ macrophages; (e) ratio of CD163+/CD86+ macrophages in endometriosis patients with stage I + II versus stage III + IV disease; (f) percentages of HLA-DR+ macrophages; (g) CD86 mRNA; (h) CD163 mRNA; (i) IL-12 mRNA; (j) IL-10 mRNA. EMs: endometriosis patients. , , .